Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Systems (272210) Announces Investor Relations (IR) Event for Q3 2025 Earnings Presentation

Posted on October 31, 2025July 22, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Systems (272210) Announces Investor Relations (IR) Event for Q3 2025 Earnings Presentation

Fact Source: Financial Supervisory Service DART / 2025-10-31

Disclosure Type: Investor Relations (IR) Event (Information Disclosure)

💡 Summary in 3 Seconds

Hanwha Systems is hosting an IR event for key domestic institutional investors to present its Q3 2025 business performance and conduct a Q&A session.

📊 1. [Key Disclosure Details & Financial Highlights]

  • Dates: November 3, 2025 ~ November 5, 2025 (3 days)
  • Target Audience: Key domestic institutional investors
  • Purpose: To enhance investor understanding through presentations on Q3 2025 business performance
  • Format: 1-on-1 meetings, among others
  • Sponsor: iM Securities
  • Main Agenda: Q3 2025 business results presentation and Q&A session
  • IR Material Posting: Scheduled for October 31, 2025, on the official company website (http://www.hanwhasystems.com)
  • Decision Date: October 31, 2025
  • Other Important Notes: The schedule is subject to change depending on company circumstances.

📈 2. [Professional Insight: What This Means for Investors]

This filing is an informational disclosure issued by Hanwha Systems regarding an upcoming IR conference held in conjunction with its Q3 2025 earnings release. It does not involve direct financial changes such as capital raising or corporate restructuring, but rather focuses on communicating third-quarter operational performance to market participants.

According to the filing, the event will take place primarily through 1-on-1 meetings, with corresponding IR documentation made available on the company website on October 31, 2025. Monitoring whether the event proceeds according to the scheduled timeline represents the primary administrative checkpoint.

📝 Editor’s Comment (by K-STOCK Editor)

The objective fact established in this filing is that Hanwha Systems is holding a three-day IR event from November 3 to November 5, 2025, targeted at domestic institutional investors.

The primary objective checkpoints for investors moving forward are verifying the official IR materials published on the company’s website on October 31, 2025, and tracking whether the event schedule remains unchanged. As the filing explicitly notes that the timeline may shift due to company circumstances, checking for any follow-up scheduling updates is advised.

📢 Disclaimer & Source Notice

Source: This content was newly structured and written based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) Reports Q3 2025 Tentative Earnings: Revenue KRW 807.7B (YoY +26.41%), Operating Profit KRW 22.5B (YoY -62.67%)
Next Post: [Disclosure] Celltrion 068270 Signs KRW 712.5B Co-Development and License Agreement with Mustbio for Tri-specific Fusion Protein Therapeutics

Related Posts

[Disclosure] SK hynix (000660) Publishes 2024 Sustainability Report, Aligning ‘AI First Mover’ Performance with Global ESG Frameworks Semiconductors
[Disclosure] Samsung Biologics (207940) Stock Futures and Options to Be Suspended from Trading Starting October 30 Due to Underlying Asset Halt Disclosures
[Disclosure] Celltrion (068270) Secures FDA Approval to Modify Phase 3 Clinical Trial Plan for ‘CT-P55’ (Cosentyx Biosimilar) Disclosures
[Disclosure] Hanwha Ocean (042660) Files Amendment for Single Sales/Supply Contract with Affiliate Updating Contract Amount to KRW 293.2B Disclosures
[Disclosure] Celltrion (068270) Secures European Commission (EC) Final Marketing Authorization for ‘Eylea Biosimilar (CT-P42)’ Disclosures
[Disclosure] Samsung Biologics (207940) Designated as Short-Selling Overheated Stock… Short-Selling Banned on January 23 for 1 Day Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme